112 research outputs found

    La naissance de l'ARDIST

    Get PDF
    Anniversaire 10 ans de l'ARDISTInternational audienceCet article, écrit par deux des acteurs qui ont participé à la création de l'ARDIST, décrit la naissance de l'ARDIST en 1998. Avant cette date existaient deux communautés séparées de didacticiens des sciences expérimentales, celle des sciences physiques et celle des sciences biologiques et géologiques. Le contexte de la création est rappelé et sont évoqués les problÚmes qui ont été soulevés et résolus pour aboutir à une fusion des deux communautés

    Sciences, techniques et pratiques professionnelles

    Get PDF

    Les jeunes enfants peuvent-ils acquérir des connaissances sur le monde physique en utilisant un simulateur ?

    Get PDF
    Dans le contexte d’une exposition pour jeunes enfants Ă  la CitĂ© des sciences et de l’industrie, deux Ă©tudes ont Ă©tĂ© rĂ©alisĂ©es avec l’objectif d’évaluer si l’utilisation d’un dispositif multimĂ©dia simulant des mĂ©langes de couleurs leur permet ultĂ©rieurement de rĂ©aliser les mĂ©langes appropriĂ©s pour obtenir des couleurs dĂ©terminĂ©es. La premiĂšre Ă©tude a portĂ© sur vingt enfants ĂągĂ©s de 2 ans et 6 mois Ă  5 ans et 6 mois observĂ©s dans un contexte expĂ©rimental de manipulation, sous la conduite d’un tuteur expert. Les analyses conduites, visant Ă  cerner l’ñge Ă  partir duquel les enfants sont capables de mettre en oeuvre des procĂ©dures acquises au moyen du simulateur dans des conditions favorables d’accompagnement, mettent en Ă©vidence que pour le domaine de connaissance considĂ©rĂ©, l’ñge de 4 ans semble constituer un palier. La seconde Ă©tude a donc concernĂ© des enfants ĂągĂ©s d’au moins 4 ans (vingt-cinq au total) observĂ©s dans le contexte habituel d’utilisation, accompagnĂ©s soit d’un parent soit d’un animateur. La comparaison de leurs conduites Ă  un prĂ©test et Ă  un posttest (tĂąche de coloriage avec des objets matĂ©riels) a permis d’évaluer l’apport de l’usage du simulateur. Les rĂ©sultats montrent que celui-ci peut permettre l’acquisition de connaissances sur le monde physique, mais que le rĂŽle de l’adulte qui exerce le tutorat reste dĂ©terminant pour les enfants de moins de 5 ans

    Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: a study from the Chronic Malignancies Working Party of the EBMT

    Get PDF
    We investigated extramedullary disease in newly diagnosed multiple myeloma patients and its impact on outcome following first-line autologous stem cell transplantation. We identified 3744 adult myeloma patients who received up-front single (n=3391) or tandem transplantation (n=353) between 2005 and 2014 with available data on extramedullary involvement at diagnosis. The overall incidence of extramedullary disease was 18.2% (n=682) and increased per year from 6.5% (2005) to 23.7% (2014). Paraskeletal involvement was found in 543 (14.5%) and extramedullary organ involvement in 139 (3.7%). More patients with extramedullary organ involvement had multiple involved sites (>= 2; P<0.001). In a comparison of patients with single sites with patients without the disease, up-front transplantation resulted in at least similar 3-year progression-free survival (paraskeletal: P=0.86, and extramedullary organ: P=0.88). In single paraskeletal involvement, this translated less clearly into worse 3-year overall survival (P=0.07) while single organ involvement was significantly worse (P=0.001). Multiple organ sites were associated with worse outcome (P<0.001 and P=0.01). First-line treatment with tandem compared with single transplantation resulted in similar survival in patients with extramedullary disease at diagnosis (P=0.13 for both)

    Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: A study from the Chronic Malignancies Working Party of the EBMT

    Get PDF
    We investigated extramedullary disease in newly diagnosed multiple myeloma patients and its impact on outcome following first line autologous stem cell transplantation. We identified 3744 adult myeloma patients who received upfront single (n = 3391) or tandem transplantation (n = 353) between 2005 and 2014 with available data on extramedullary in-volvement at diagnosis. The overall incidence of extramedullary disease was 18.2% (n = 682) and increased per year from 6.5% (2005) to 23.7% (2014). Paraskeletal involvement was found in 543 (14.5%) and extramedullary organ involvement in 139 (3.7%) while the majority of 3062 (81.8%) patients had no extramedullary disease. More patients with extramedul-lary organ involvement had multiple involved sites (>/=2;) (p < 0.001). In patients with single sites compared to patients without the disease, upfront transplantation resulted in at least similar 3-year progression-free survival (paraskeletal: p = 0.86, and extramedullary organ: p = 0.88). In single paraskeletal involvement, this translated less clearly into 3-year overall survival (p = 0.07) while single organ involvement was significantly worse (p = 0.001). Multiple organ sites were associated with worse outcome (p < 0.001 and p = 0.01). First line treatment with tandem compared with single transplantation resulted in similar survival in patients with extramedullary disease at diagnosis (p = 0.13, respectively)

    Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma

    Get PDF
    [Excerpt] Multiple myeloma (MM) is the third most common hematological malignancy, after Non-Hodgkin Lymphoma and Leukemia. MM is generally preceded by Monoclonal Gammopathy of Undetermined Significance (MGUS) [1], and epidemiological studies have identified older age, male gender, family history, and MGUS as risk factors for developing MM [2]. The somatic mutational landscape of sporadic MM has been increasingly investigated, aiming to identify recurrent genetic events involved in myelomagenesis. Whole exome and whole genome sequencing studies have shown that MM is a genetically heterogeneous disease that evolves through accumulation of both clonal and subclonal driver mutations [3] and identified recurrently somatically mutated genes, including KRAS, NRAS, FAM46C, TP53, DIS3, BRAF, TRAF3, CYLD, RB1 and PRDM1 [3,4,5]. Despite the fact that family-based studies have provided data consistent with an inherited genetic susceptibility to MM compatible with Mendelian transmission [6], the molecular basis of inherited MM predisposition is only partly understood. Genome-Wide Association (GWAS) studies have identified and validated 23 loci significantly associated with an increased risk of developing MM that explain ~16% of heritability [7] and only a subset of familial cases are thought to have a polygenic background [8]. Recent studies have identified rare germline variants predisposing to MM in KDM1A [9], ARID1A and USP45 [10], and the implementation of next-generation sequencing technology will allow the characterization of more such rare variants. [...]French National Cancer Institute (INCA) and the Fondation Française pour la Recherche contre le Myélome et les Gammapathies (FFMRG), the Intergroupe Francophone du Myélome (IFM), NCI R01 NCI CA167824 and a generous donation from Matthew Bell. This work was supported in part through the computational resources and staff expertise provided by Scientific Computing at the Icahn School of Medicine at Mount Sinai. Research reported in this paper was supported by the Office of Research Infrastructure of the National Institutes of Health under award number S10OD018522. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors thank the Association des Malades du Myélome Multiple (AF3M) for their continued support and participation. Where authors are identified as personnel of the International Agency for Research on Cancer / World Health Organization, the authors alone are responsible for the views expressed in this article and they do not necessarily represent the decisions, policy or views of the International Agency for Research on Cancer / World Health Organizatio

    Baron (G.-L.), Bruillard (E.). — L'informatique et ses usagers dans l'Ă©ducation

    No full text
    Caillot Michel. Baron (G.-L.), Bruillard (E.). — L'informatique et ses usagers dans l'Ă©ducation. In: Revue française de pĂ©dagogie, volume 120, 1997. Penser la pĂ©dagogie. pp. 153-154

    Baron (G.-L.), Bruillard (E.). — L'informatique et ses usagers dans l'Ă©ducation

    No full text
    Caillot Michel. Baron (G.-L.), Bruillard (E.). — L'informatique et ses usagers dans l'Ă©ducation. In: Revue française de pĂ©dagogie, volume 120, 1997. Penser la pĂ©dagogie. pp. 153-154

    Sciences, techniques et pratiques professionnelles

    No full text
    Caillot Michel. Sciences, techniques et pratiques professionnelles. In: Aster, recherches en didactique des sciences expérimentales, n°34, 2002. Sciences, techniques et pratiques professionnelles. pp. 3-8
    • 

    corecore